May 15th 2024
Roche's innovative human papillomavirus self-collection solution offers a breakthrough in cervical cancer screening, providing accessible and reliable testing to combat underscreening rates and increase early detection.
Risks of cervical excisional treatment and PPROM
June 30th 2023In a recent study, pregnancies with preterm prelabor rupture of membranes were associated with greater risks of intraamniotic infection, microbial invasion of the amniotic cavity without inflammation, and early-onset neonatal sepsis development in women with a history of cervical excisional treatment.
Read More
The value of HPV self-sampling kits
May 31st 2023Jeff Andrews, MD, FRCSC, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, discusses the link between human papillomavirus (HPV) and cervical cancer, and how HPV self-sampling kits may increase rates of cervical cancer screening.
Read More